Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Löfgren

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Journal of Cancer|June 16, 2023
<i>Porphyromonas gingivalis</i> in Colorectal Cancer and its Association to Patient PrognosisMaïwenn Kerdreux, Sofia Edin, Thyra Löwenmark, et al.
Plos One|July 11, 2014
SOX2 expression is regulated by BRAF and contributes to poor patient prognosis in colorectal cancerIda V Lundberg, Anna Löfgren Burström, Sofia Edin, et al.
Scientific Reports|March 27, 2020
A longitudinal study of prediagnostic metabolic biomarkers and the risk of molecular subtypes of colorectal cancerRobin Myte, Sophia Harlid, Anneli Sundkvist, et al.
Oncoimmunology|August 21, 2025
Differential distribution of immune checkpoints across molecular subtypes of colorectal cancerSofia Edin, Björn Gylling, Xingru Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 23, 2020
C-reactive Protein and Future Risk of Clinical and Molecular Subtypes of Colorectal CancerStina Bodén, Robin Myte, Justin Harbs, et al.
Oncoimmunology|November 18, 2017
TAP1 down-regulation elicits immune escape and poor prognosis in colorectal cancerAgnes Ling, Anna Löfgren-Burström, Pär Larsson, et al.
Cancers|April 16, 2020
Ex Vivo Organoid Cultures Reveal the Importance of the Tumor Microenvironment for Maintenance of Colorectal Cancer Stem CellsXingru Li, Pär Larsson, Ingrid Ljuslinder, et al.
Anticancer Research|January 29, 2018
MicroRNA Expression in <i>KRAS</i>- and <i>BRAF</i>-mutated Colorectal CancersIda V Lundberg, Maria L Wikberg, Ingrid Ljuslinder, et al.
Scientific Reports|September 18, 2020
Parvimonas micra as a putative non-invasive faecal biomarker for colorectal cancerThyra Löwenmark, Anna Löfgren-Burström, Carl Zingmark, et al.
International Journal of Cancer|August 24, 2017
Cancer-associated fecal microbial markers in colorectal cancer detectionVincy Eklöf, Anna Löfgren-Burström, Carl Zingmark, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Journal of Cancer|June 16, 2023
<i>Porphyromonas gingivalis</i> in Colorectal Cancer and its Association to Patient PrognosisMaïwenn Kerdreux, Sofia Edin, Thyra Löwenmark, et al.
Plos One|July 11, 2014
SOX2 expression is regulated by BRAF and contributes to poor patient prognosis in colorectal cancerIda V Lundberg, Anna Löfgren Burström, Sofia Edin, et al.
Scientific Reports|March 27, 2020
A longitudinal study of prediagnostic metabolic biomarkers and the risk of molecular subtypes of colorectal cancerRobin Myte, Sophia Harlid, Anneli Sundkvist, et al.
Oncoimmunology|August 21, 2025
Differential distribution of immune checkpoints across molecular subtypes of colorectal cancerSofia Edin, Björn Gylling, Xingru Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 23, 2020
C-reactive Protein and Future Risk of Clinical and Molecular Subtypes of Colorectal CancerStina Bodén, Robin Myte, Justin Harbs, et al.
Oncoimmunology|November 18, 2017
TAP1 down-regulation elicits immune escape and poor prognosis in colorectal cancerAgnes Ling, Anna Löfgren-Burström, Pär Larsson, et al.
Cancers|April 16, 2020
Ex Vivo Organoid Cultures Reveal the Importance of the Tumor Microenvironment for Maintenance of Colorectal Cancer Stem CellsXingru Li, Pär Larsson, Ingrid Ljuslinder, et al.
Anticancer Research|January 29, 2018
MicroRNA Expression in <i>KRAS</i>- and <i>BRAF</i>-mutated Colorectal CancersIda V Lundberg, Maria L Wikberg, Ingrid Ljuslinder, et al.
Scientific Reports|September 18, 2020
Parvimonas micra as a putative non-invasive faecal biomarker for colorectal cancerThyra Löwenmark, Anna Löfgren-Burström, Carl Zingmark, et al.
International Journal of Cancer|August 24, 2017
Cancer-associated fecal microbial markers in colorectal cancer detectionVincy Eklöf, Anna Löfgren-Burström, Carl Zingmark, et al.
Pageof 4